drugset / Trial / NCT06957327
A Study of ERAS-601 in People With Chordoma
NaSingle-groupOpen-labelTreatment
Summary
The researchers are doing this study is to find out whether ERAS-601 is a safe and effective treatment that causes few or mild side effects in people with advanced and progressing chordoma.
Timeline
- Start
- 2025-04-25
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ERAS-601 | Unknown | 40 mg | — |